Transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the neonatal Parkinsonian rat caudate putamen

Journal of Neuroscience Research

Volumn 85, Issue 4, 2007, Pages 778-786

  Haas, Stefan Jean Pierre ^a   Beckmann, Stephan ^a   Petrov, Stanislav ^a   Andressen, Christian ^a   Wree, Andreas ^a   Schmitt, Oliver ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

6 OHDA; Cell therapy; Neural progenitor cell; Parkinson's disease; PKH26

Indexed keywords

OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; BRAIN REGION; BRAIN SLICE; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRUCTURE; CELL TRANSPLANTATION; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RAT; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; DISEASE MODELS, ANIMAL; MALE; MESENCEPHALON; NEOSTRIATUM; ORGANIC CHEMICALS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; STEM CELL TRANSPLANTATION; STEM CELLS; TYROSINE 3-MONOOXYGENASE;

EID: 33947202802     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21170     Document Type: Article

References (67)

1. Anton R, Kordower JH, Maidment NT, Manaster JB, Kane DJ, Rabizadeh S, Schueler SB, Yang J, Rabizadeh S, Edwards RH, Markham CH, Bredesen DE. 1994. Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp Neurol 127:207-218.
2. Anton R, Kordower JH, Kane DJ, Markham CH, Bredesen DE. 1995. Neural transplantation of cells expressing the anti-apoptotic gene bcl-2. Cell Transplant 4:49-54.
3. Apuzzo ML, Neal JH, Waters CH, Appley AJ, Boyd SD, Couldwell WT, Wheelock VH, Weiner LP. 1990. Utilization of unilateral and bilateral stereotactically placed adrenomedullary-striatal autografts in parkinsonian humans: rationale, techniques, and observations. Neurosurgery 26:746-757.
4. Backlund EO, Granberg PO, Hamberger B, Knutsson E, Martensson A, Sedvall G, Seiger A, Olson L. 1985. Transplantation of adrenal medullary tissue to striatum in parkinsonism: first clinical trials. J Neurosurg 2:169-173.
5. Ballif BA, Villen J, Beausoleil SA, Schwartz D, Gygi SP. 2004. Phosphoproteomic analysis of the developing mouse brain. Mol Cell Proteomics 3:1093-1101.
6. Bentlage C, Nikkhah G, Cunningham MG, Björklund A. 1999. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Exp Neurol 159:177-190.
7. Björklund A. 1992. Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr Opin Neurobiol 2:683-689.
8. Björklund A, Lindvall O. 2000. Cell replacement therapies for central nervous system disorders. Nat Neurosci 3:537-544.
9. Brundin P, Wictorin K. 1993. Neural transplantation in rat models of Parkinson's and Huntington's diseases. Semin Neurosci 5:413-421.
10. Brunet JF, Rouiller E, Wannier T, Villemure JG, Bloch J. 2005. Primate adult brain cell autotransplantation, a new tool for brain repair? Exp Neurol 196:195-198.
11. Cattaneo E, Conti L. 1998. Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J Neurosci Res 53:223-234.
12. Costantini LC, Isacson O. 1999. Dopamine neuron grafts: Development and molecular biology. In: di Porzio U, Pernas-Alosno R, Perrone-Capano C, editors. Development of dopaminergic neurons. Georgetown: R.G. Landes. p 123-144.
13. Cunningham MG, McKay RD. 1993. A hypothermic miniaturized stereotaxic instrument for surgery in newborn rats. J Neurosci Methods 47:105-114.
14. Deacon T, Schumacher J, Dinsmore J, Thomas C, Palmer P, Kott S, Edge A, Penney D, Kassissieh S, Dempsey P, Isacson O. 1997. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 3:350-353.
15. Doetsch F. 2003. A niche for adult neural stem cells. Curr Opin Genet Dev 13:543-550.
16. Dunnett SB, Björklund A. 1999. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399(Suppl):32-39.
17. Ermert L, Hocke AC, Duncker HR, Seeger W, Ermert M. 2001. Comparison of different detection methods in quantitative microdensitometry. Am J Pathol 158:407-417.
18. Espejo EF, Montoro RJ, Armengol JA, Lopez-Barneo J. 1998. Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron 20:197-206.
19. Fountoulakis M, Schuller E, Hardmeier R, Berndt P, Lubec G. 1999. Rat brain proteins: two-dimensional protein database and variations in the expression level. Electrophoresis 20:3572-3579.
20. Frederiksen K, Jat PS, Valtz N, Levy D, McKay RDG. 1988. Immortalization of precursor cells from the mammalian CNS. Neuron 1:439-448.
21. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. 2001. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710-719.
22. Goetz CG, Olanow CW, Koller WC, Penn RD, Cahill D, Morantz R, Stebbins G, Tanner CM, Klawans HL, Shannon KM. 1989. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med 320:337-341.
23. Goetz CG, Stebbins GT 3rd, Klawans HL, Koller WC, Grossman RG, Bakay RA, Penn RD. 1991. United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1-and 2-year follow-up. Neurology 41:1719-1722.
24. Haas SJP, Wree A. 2002. Dopaminergic differentiation of the Nurr1-expressing immortalized mesencephalic cell line CSM14.1 in vitro. J Anat 201:61-69.
25. Haas SJP, Bauer P, Rolfs A, Wree A. 2000. Immunocytochemical characterization of in vitro PKH26-labelled and intracerebrally transplanted neonatal cells. Acta Histochem 102:273-280.
26. Hedner T, Lundborg P. 1981. Neurochemical characteristics of cerebral catecholamine neurons during the postnatal development in the rat. Med Biol 59:212-223.
27. Herman JP, Abrous ND. 1994. Dopaminergic neural grafts after fifteen years: results and perspectives. Prog Neurobiol 44:1-35.
28. Herman JP, Abrous DN, LeMoal M. 1991. Anatomical and behavioral comparison of unilateral dopamine-rich grafts implanted into the striatum of neonatal and adult rats. Neuroscience 40:465-475.
29. Joosten EA, Veldhuis WB, Hamers FP. 2004. Collagen containing neonatal astrocytes stimulates regrowth of injured fibers and promotes modest locomotor recovery after spinal cord injury. J Neurosci Res 77:127-142.
30. Joyce JN, Frohna PA, Neal-Beliveau BS. 1996. Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neurosci Biobehav Rev 20:453-486.
31. Kirik D, Rosenblad C, Björklund A. 1998. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152:259-277.
32. Kirik D, Rosenblad C, Björklund A, Mandel RJ. 2000. Long-term, rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci 20:4686-4700.
33. Kordower JH, Cochran E, Penn RD, Goetz CG. 1991. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann Neurol 29:405-412.
34. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP. 1995. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N EnglJ Med 332:1118-1124.
35. Krobert K, Lopez-Colberg I, Cunningham LA. 1997. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon cografts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor. Exp Neurol 145:511-523.
36. Lindvall O. 1997. Neural transplantation: a hope for patients with Parkinson's disease. Neuroreport 8:iii-x.
37. Lindvall O, Hagell P. 2002a. Cell replacement therapy in human neurodegenerative disorders. Clin Neurosci Res 2:86-92.
38. Lindvall O, Hagell P. 2002b. Neural and stem cell transplantation. In: Jankovic JJ, Tolosa E, editors. Parkinsons's and movement disorders. Philadelphia: Lippincott Williams and Wilkins. p 663-673.
39. Luquin MR, Montoro RJ, Guillén J, Saldise L, Insausti R, Del Rio J, Lopez-Barneo J. 1999. Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron 22: 743-750.
40. Luthman J, Herrera-Marschitz M, Lindqvist E. 1994. Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behavior and on postmortem monoamine levels. Psychopharmacology 116:443-450.
41. Martinez-Serrano A, Björklund A. 1997. Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci 20:530-538.
42. Mendez I, Sadi D, Hong M. 1996. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J Neurosci 16:7216-7227.
43. Mohapel P, Frielingsdorf H, Haggblad J, Zachrisson O, Brundin P. 2005. Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience 132:767-776.
44. Neal-Beliveau BS, Joyce JN. 1999. Timing: a critical determinant of the functional consequences of neonatal 6-OHDA lesions. Neurotoxicol Teratol 21:129-140.
45. Nikkhah G, Cunningham MG, Cenci MA, McKay RD, Björklund A. 1995a. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostrial pathway. J Neurosci 15:3548-3561.
46. Nikkhah G, Cunningham MG, McKay RD, Björklund A. 1995b. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery. J Neurosci 15:3562-3570.
47. Oberholzer M, Östreicher M. 1996. Methods in quantitative image analysis. Histochem Cell Biol 105:333-355.
48. Olanow CW, Kordower JH, Freeman TB. 1996. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19:102-109.
49. Olanow CW, Freeman TB, Kordower JH. 1997. Neural transplantation as a therapy for Parkinson's disease. Adv Neurol 74:249-269.
50. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. 2003. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54:403-414.
51. Olson L, Strömberg I, Ebendal T, Seiker A, Hoffer B. 1991. Grafting strategies in Parkinson's disease: the chromaffin alternative. Rest Neurol 4:3-14.
52. Olsson M, Bentlage C, Wictorin K, Campbell K, Björklund A. 1997. Extensive migration and target innervation by striatal precursors after grafting into the neonatal striatum. Neuroscience 79:57-78.
53. Panchision DM, McKay RD. 2002. The control of neural stem cells by morphogenic signals. Curr Opin Genet Dev 12:478-487.
54. Piccini P, Brooks DJ, Björklund A, Gunn RN, Grasby PM, Rimoldi O, Brundin P, Hagell P, Rehncrona S, Widner H, Lindvall O. 1999. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2:1137-1140.
55. Reader TA, Dewar KM. 1999. Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease. Neurochem Int 34:1-21.
56. Redies C, Lendahl U, McKay RDG. 1991. Differentiation and heterogeneity in T-antigen immortalized precursor cell lines from mouse cerebellum. J Neurosci Res 30:601-615.
57. Saunders NR, Habgood MD, Dziegielewska KM. 1999. Barrier mechanisms in the brain, II. Immature brain. Clin Exp Pharmacol Physiol 26:85-91.
58. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. 2000. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-787.
59. Schmitt O, Lessner G, Haas SJP, Ringel B, Glocker MO, Wree A. 2007. Compartmental proteome analysis of the adult rat brain. Anat Ges (Ann Anat Suppl) (in press).
60. Shimohama S, Sawada H, Kitamura Y, Taniguchi T. 2003. Disease model: Parkinson's disease. Trends Mol Med 9:360-365.
61. Snyder EY. 1994. Grafting immortalized neurons to the CNS. Curr Opin Neurobiol 4:742-751.
62. Snyder-Keller AM, Carder RK, Lund RD. 1989. Development of dopamine innervation and turning behavior in dopamine-depletet infant rats receiving unilateral nigral transplants. Neuroscience 30:779-794.
63. Sortwell CE, Camargo MD, Pitzer MR, Gyawali S, Collier TJ. 2001. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp Neurol 169:23-29.
64. Whittemore SR, Onifer SM. 2000. Immortalized neural cell lines for CNS transplantation. Prog Brain Res 127:49-65.
65. Xavier LL, Viola GG, Ferraz AC, Da Cunha C, Deonizio JM, Netto CA, Achaval M. 2005. A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Protoc 16:58-64.
66. Yang JW, Juranville JF, Hoger H, Fountoulakis M, Lubec G. 2005. Molecular diversity of rat brain proteins as revealed by proteomic analysis. Mol Divers 9:385-396.
67. Zhong LT, Sarafiani T, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE. 1993. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A 90:4533-4537.